412 related articles for article (PubMed ID: 33428593)
1. ALKBH5-mediated m
Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
[TBL] [Abstract][Full Text] [Related]
2. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
3. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
4. ALKBH5-m
Chao Y; Shang J; Ji W
Biochem Biophys Res Commun; 2020 Jan; 521(2):499-506. PubMed ID: 31677788
[TBL] [Abstract][Full Text] [Related]
5. m
Zhang S; Zhao BS; Zhou A; Lin K; Zheng S; Lu Z; Chen Y; Sulman EP; Xie K; Bögler O; Majumder S; He C; Huang S
Cancer Cell; 2017 Apr; 31(4):591-606.e6. PubMed ID: 28344040
[TBL] [Abstract][Full Text] [Related]
6. RNA m
Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
[TBL] [Abstract][Full Text] [Related]
7. N
Zhu Z; Qian Q; Zhao X; Ma L; Chen P
Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
[TBL] [Abstract][Full Text] [Related]
8. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
[TBL] [Abstract][Full Text] [Related]
9. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
Gong H; Liu L; Cui L; Ma H; Shen L
Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
[TBL] [Abstract][Full Text] [Related]
10. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
[TBL] [Abstract][Full Text] [Related]
11. m
Xiao D; Fang TX; Lei Y; Xiao SJ; Xia JW; Lin TY; Li YL; Zhai JX; Li XY; Huang SH; Jia JS; Tian YG; Lin XL; Cai KC; Sun Y
Aging (Albany NY); 2021 Sep; 13(17):21497-21512. PubMed ID: 34491904
[TBL] [Abstract][Full Text] [Related]
12. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
13. microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
Sun M; Wang X; Tu C; Wang S; Qu J; Xiao S
Cell Biol Int; 2017 Dec; 41(12):1272-1282. PubMed ID: 28225180
[TBL] [Abstract][Full Text] [Related]
14. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
[TBL] [Abstract][Full Text] [Related]
15. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
[TBL] [Abstract][Full Text] [Related]
16. ALKBH5 facilitates the progression of skin cutaneous melanoma via mediating ABCA1 demethylation and modulating autophagy in an m
Wang H; Zhao S; Liu H; Liu Y; Zhang Z; Zhou Z; Wang P; Qi S; Xie J
Int J Biol Sci; 2024; 20(5):1729-1743. PubMed ID: 38481816
[No Abstract] [Full Text] [Related]
17. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
[TBL] [Abstract][Full Text] [Related]
18. Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.
Gong C; Shen J; Fang Z; Qiao L; Feng R; Lin X; Li S
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29899166
[TBL] [Abstract][Full Text] [Related]
19. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
[TBL] [Abstract][Full Text] [Related]
20. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.
Sun Z; Su Z; Zhou Z; Wang S; Wang Z; Tong X; Li C; Wang Y; Chen X; Lei Z; Zhang HT
FASEB J; 2022 May; 36(5):e22283. PubMed ID: 35344216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
